Bacterial LplA plus lipoic acid rescues lethal Lipt1 myopathy by restoring mitochondrial lipoylation and OXPHOS

Verdict. A bacterial lipoate ligase plus free lipoic acid rebuilds mitochondrial protein lipoylation in Lipt1-deficient mouse muscle, restores oxidative phosphorylation, and reverses lethal myopathy and hypertrophic cardiomyopathy. The salvage path does not repair mammalian Lipt1. It bypasses it.

Metal sites and redox

Lipoamide is a covalently attached cofactor, not an iron-sulfur cluster. The oxidized form is a 1,2-dithiolane (cyclic disulfide). The reduced form is dihydrolipoamide, a dithiol that carries the acyl intermediate on pyruvate dehydrogenase E2, 2-oxoglutarate dehydrogenase E2, branched-chain ketoacid dehydrogenase E2, and glycine-cleavage H protein. Lipt1 is the mammalian transferase that installs that cofactor. Bacterial LplA is an ATP-dependent ligase that attaches free lipoic acid to the same lysine. This abstract does not name an Fe-S nuclearity, a heme, or NAD+/NADH as a measured couple. Do not invent [4Fe-4S] chemistry at Lipt1. The redox actor here is the lipoamide disulfide/dithiol.

What the authors report

Inherited mitochondrial lipoylation defects can be lethal and have lacked effective treatment. Whole-body Lipt1 loss is embryonically lethal, so the authors built a muscle-specific Lipt1-deficient mouse that lives long enough to treat. They deliver bacterial lipoate protein ligase A by adeno-associated virus and supplement lipoic acid, reconstituting a salvage pathway that bypasses endogenous mammalian lipoylation. The intervention rescued premature lethality, recovered motor function, and reversed hypertrophic cardiomyopathy. Mechanistically, AAV-LplA reconstitutes mitochondrial protein lipoylation and oxidative phosphorylation in situ. That energetic rescue suppresses PI3K-Akt hyperactivation, restores autophagic clearance, and contributes to recovery of the pathological phenotype. They present AAV-LplA as a gene-delivery strategy for lethal mitochondrial lipoylation disorders.

What was measured

Muscle-specific Lipt1 loss, AAV-LplA plus lipoic acid, mitochondrial protein lipoylation, oxidative phosphorylation, PI3K-Akt signaling, autophagic clearance, motor function, hypertrophic cardiomyopathy, and survival. Serotype, vector dose, and which lipoylated enzymes recovered are not in the abstract.

Caveats

Abstract only. Preprint. Muscle-restricted model. Immune recognition of a bacterial ligase is untested here. Which 2-oxoacid dehydrogenase actually regained lipoyl occupancy is unnamed.

What to do with it

Treat lethal Lipt1 myopathy as a missing lipoamide cofactor problem that a bacterial ligase plus free lipoate can bypass. The molecular test is whether E2 and H-protein lipoylation, OXPHOS, and the PI3K-Akt/autophagy couple recover together in muscle, and whether that recovery holds outside a mouse AAV experiment.

Bibliographic record

Abstract-based editorial synthesis by Mitos. Not peer review.